July 16, 2021

(Reuters) – The U.S. Food and Drug Administration set a deadline of January next year for its review of Pfizer and BioNTech SE’s COVID-19 vaccine’s use in people 16 years of age and older, the companies said on Friday.

(Reporting by Manojna Maddipatla in Bengaluru)

Leave a Reply

Your email address will not be published. Required fields are marked *